19 /100
LOW RISK
Score updated May 29, 2026

CATX — Perspective Therapeutics, Inc. Dilution Risk Tracker

Track CATX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CATX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
30
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
9%
💰 Capital Raise 18%
• Active ATM program with $500M remaining capacity
🔔 Track CATX — Get forecast alerts →

💹 Market Data

Market Cap$461.89M
Shares Outstanding114.05M
Float74.34M
Cash$270.93M
Debt$4.23M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 13.6% shares (2025Q4 vs prior)
115 institutional holders · 37.55M shares
#1 BlackRock, Inc. 4.56M shares
#2 MORGAN STANLEY 4.47M shares
#3 VANGUARD GROUP INC 3.49M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest13.00M
Days to Cover8.4
% of Float17.5%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Jun 30, 2018
4 INSIDER TRANSACTION Mar 04, 2026
4 INSIDER TRANSACTION Mar 04, 2026
4 INSIDER TRANSACTION Mar 04, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track CATX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CATX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAON ABLZF ACIW ADM
🔬 More Research for CATX
📊 CATX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CATX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.